|1.||Baruah, Paramita: 2 articles (07/2012 - 03/2012)|
|2.||Dumitriu, Ingrid E: 2 articles (07/2012 - 03/2012)|
|3.||Kaski, Juan Carlos: 2 articles (07/2012 - 03/2012)|
|4.||Butler, Noah S: 1 article (05/2015)|
|5.||Kulu, Divine I: 1 article (05/2015)|
|6.||Ongoiba, Aissata: 1 article (05/2015)|
|7.||Guthmiller, Jenna J: 1 article (05/2015)|
|8.||Obeng-Adjei, Nyamekye: 1 article (05/2015)|
|9.||Crompton, Peter D: 1 article (05/2015)|
|10.||Zander, Ryan A: 1 article (05/2015)|
08/01/2011 - "Our previous studies have implicated signaling through the tumor necrosis family receptors OX40 and CD30 as critical for maintaining CD4 memory responses. "
05/11/2009 - "We report that the combined use of the alkylating agent cyclophosphamide (CTX) and an agonist antibody targeting the co-stimulatory receptor OX40 (OX86) provides potent antitumor immunity capable of regressing established, poorly immunogenic B16 melanoma tumors. "
|4.||Acute Coronary Syndrome
03/01/2013 - "To investigate the variations of OX40 (tumor necrosis factor receptor superfamily, member 4) and its ligand OX40L genes and their relationships with serum lipids and apolipoproteins (apo) levels in Chinese healthy individuals and patients with endogenous hypertriglyceridemia (HTG) in the Chengdu area. "